| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |